Vanc Pharmaceuticals CEO resigns; interim named

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
Webinar ReplaysNew Corporate Realities: Blending Geopolitics, Data, and Digital Transformation
- 07/21/2022
- On-Demand
- 1 Hour
In PersonInteract 2022
- 09/15/2022
- 225 Liberty Street, New York, New York
- 225 Liberty Street
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
Platforms
Other Products
- Research Online

In This List

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations

30 Jan, 2017 | 03:36

Author Ayesha Hassan
Theme Healthcare & Pharmaceuticals

Vanc Pharmaceuticals Inc. CEO Arun Nayyar resigned, effective immediately.

Bob Rai replaced Nayyar on an interim basis. Rai, who has been a director at Vanc since June 2015, is chairman and CEO of Canada Pacific Global Pharmaceuticals.